Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
090430.KS
Top 10 Correlated ETFs
090430.KS
Top 10 Correlated Stocks
090430.KS
Financial details
Company Rating
Buy
Market Cap
6404.23B
Income
84.04B
Revenue
4544.44B
Book val./share
69450.76
Cash/share
-
Dividend
980
Dividend %
0.96%
Employees
4.78K
Optionable
No
Shortable
Yes
Earnings
27 Oct 2022
P/E
83.59
Forward P/E
-
PEG
6.04
P/S
1.55
P/B
1.47
P/C
-
P/FCF
29.23
Quick Ratio
-
Current Ratio
1.95
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.22K
EPS next Y
-
EPS next Q
-
EPS this Y
552.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.16%
Revenue last 5Y
-1.04%
Revenue Q/Q
-18.82%
EPS Q/Q
-126.22%
-
-
-
-
SMA20
-10.36%
SMA50
-18.24%
SMA100
-36.24%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.04%
Gross Margin
70%
Oper. Margin
5%
Profit Margin
2%
Payout
80%
Shs Outstand
58.44M
Shs Float
38.8M
-
-
-
-
Target Price
-
52W Range
101500.0-195000.0
52W High
-47.69%
52W Low
+0.49%
RSI
29
Rel Volume
1.2
Avg Volume
207.21K
Volume
248.29K
Perf Week
-13.19%
Perf Month
-20.31%
Perf Quarter
-33.77%
Perf Half Y
-38.37%
-
-
-
-
Beta
0.931418
-
-
Volatility
3579.99%, 6749.18%
Prev Close
0%
Price
102000
Change
-2.39%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 87.7K | 90.33K | 96.07K | 76.48K | 83.92K | |
| Net income per share | 6.74K | 5.69K | 4.11K | 606.26 | 3.34K | |
| Operating cash flow per share | 8.77K | 11.07K | 12.37K | 9.57K | 11.93K | |
| Free cash flow per share | -5.11K | 3.25K | 7.52K | 5.86K | 9.84K | |
| Cash per share | 11.4K | 13.36K | 15.18K | 17.57K | 19.51K | |
| Book value per share | 71.1K | 75.69K | 77.29K | 77.1K | 82.16K | |
| Tangible book value per share | 67.36K | 71.75K | 73.56K | 73.44K | 78.39K | |
| Share holders equity per share | 71.1K | 75.69K | 77.29K | 77.1K | 82.16K | |
| Interest debt per share | 2.27K | 2.03K | 10.07K | 7.55K | 6.93K | |
| Market cap | 18082.68B | 10428.94B | 11268.09B | 12922.72B | 8982.16B | |
| Enterprise value | 17608B | 9809.57B | 11159.37B | 12549.76B | 8834.57B | |
| P/E ratio | 45.89 | 31.39 | 47.19 | 367.83 | 46.38 | |
| Price to sales ratio | 3.53 | 1.98 | 2.02 | 2.92 | 1.85 | |
| POCF ratio | 35.28 | 16.13 | 15.69 | 23.31 | 12.99 | |
| PFCF ratio | -60.52 | 54.9 | 25.79 | 38.08 | 15.75 | |
| P/B Ratio | 4.35 | 2.36 | 2.51 | 2.89 | 1.89 | |
| PTB ratio | 4.35 | 2.36 | 2.51 | 2.89 | 1.89 | |
| EV to sales | 3.44 | 1.86 | 2 | 2.83 | 1.82 | |
| Enterprise value over EBITDA | 22.29 | 13.65 | 12.52 | 24.41 | 12.92 | |
| EV to operating cash flow | 34.35 | 15.17 | 15.54 | 22.64 | 12.78 | |
| EV to free cash flow | -58.93 | 51.64 | 25.54 | 36.98 | 15.49 | |
| Earnings yield | 0.02 | 0.03 | 0.02 | 0 | 0.02 | |
| Free cash flow yield | -0.02 | 0.02 | 0.04 | 0.03 | 0.06 | |
| Debt to equity | 0.01 | 0.01 | 0.06 | 0.03 | 0.02 | |
| Debt to assets | 0.22 | 0.17 | 0.25 | 0.22 | 0.22 | |
| Net debt to EBITDA | -0.6 | -0.86 | -0.12 | -0.73 | -0.22 | |
| Current ratio | 1.6 | 2.05 | 1.69 | 1.89 | 1.74 | |
| Interest coverage | 193.63 | 206.42 | 21.42 | 8.4 | 30.09 | |
| Income quality | 1.3 | 1.95 | 3.01 | 15.78 | 3.57 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.28 | 0.27 | 0.34 | 1.95 | 0.28 | |
| Sales general and administrative to revenue | 0.08 | 0.08 | 0.05 | 0.04 | 0.04 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.04 | 0.05 | 0.04 | 0.04 | 0.03 | |
| Capex to operating cash flow | -1.58 | -0.71 | -0.39 | -0.39 | -0.18 | |
| Capex to revenue | -0.16 | -0.09 | -0.05 | -0.05 | -0.02 | |
| Capex to depreciation | -3.63 | -1.72 | -0.58 | -0.47 | -0.33 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 103.86K | 98.4K | 84.56K | 32.43K | 78.6K | |
| ROIC | 0.14 | 0.1 | 0.09 | 0.03 | 0.07 | |
| Return on tangible assets | 0.08 | 0.06 | 0.04 | 0.01 | 0.03 | |
| Graham Net | -5.93K | 984.96 | -6.58K | -210.62 | 78.62 | |
| Working capital | 631.03B | 804.02B | 736.5B | 859.79B | 861.04B | |
| Tangible asset value | 3935.64B | 4192.3B | 4272.32B | 4255.62B | 4542.62B | |
| Net current asset value | 477.17B | 642.52B | 312.9B | 588.21B | 646.11B | |
| Invested capital | 0.03 | 0.03 | 0.13 | 0.09 | 0.08 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 124.85B | 114.73B | 145.04B | 117.62B | 120.51B | |
| Average inventory | 394.62B | 408.89B | 433.54B | 414.48B | 453.85B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 34.94 | 28.45 | 41.95 | 33.93 | 33.06 | |
| Days of inventory on hand | 99.14 | 102.59 | 110.09 | 119.56 | 132.12 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 10.45 | 12.83 | 8.7 | 10.76 | 11.04 | |
| Inventory turnover | 3.68 | 3.56 | 3.32 | 3.05 | 2.76 | |
| ROE | 0.09 | 0.08 | 0.05 | 0.01 | 0.04 | |
| Capex per share | -13.89K | -7.82K | -4.85K | -3.71K | -2.09K |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 17.18K | 16.1K | 19.24K | 16.92K | 13.73K | |
| Net income per share | 892 | 579 | -616.65 | 1.7K | -447.01 | |
| Operating cash flow per share | 2.84K | 1.49K | 4.62K | -778.62 | -135.43 | |
| Free cash flow per share | 2.42K | 1.03K | 4.18K | -1.24K | -484.03 | |
| Cash per share | 16.4K | 15.82K | 16.41K | 0 | 0 | |
| Book value per share | 67.48K | 70.41K | 69.13K | 69.91K | 69.45K | |
| Tangible book value per share | 64.48K | 67.4K | 65.96K | 69.7K | 69.13K | |
| Share holders equity per share | 67.48K | 70.41K | 69.13K | 69.91K | 69.45K | |
| Interest debt per share | 5.34K | 5.9K | 5.66K | -44.58 | -94.41 | |
| Market cap | 17258.06B | 12293.35B | 11501.34B | 11019.25B | 8953.14B | |
| Enterprise value | 17049.11B | 12127.91B | 11353.75B | 11019.25B | 8953.14B | |
| P/E ratio | 70.63 | 77.07 | -67.7 | 23.46 | -72.71 | |
| Price to sales ratio | 14.67 | 11.09 | 8.68 | 9.46 | 9.47 | |
| POCF ratio | 88.66 | 119.87 | 36.15 | -205.49 | -959.92 | |
| PFCF ratio | 104.08 | 173.06 | 39.92 | -128.88 | -268.58 | |
| P/B Ratio | 3.73 | 2.54 | 2.42 | 2.29 | 1.87 | |
| PTB ratio | 3.73 | 2.54 | 2.42 | 2.29 | 1.87 | |
| EV to sales | 14.49 | 10.94 | 8.57 | 9.46 | 9.47 | |
| Enterprise value over EBITDA | 105.09 | 95.13 | 221.03 | 70.39 | -478.71 | |
| EV to operating cash flow | 87.59 | 118.26 | 35.69 | -205.49 | -959.92 | |
| EV to free cash flow | 102.82 | 170.73 | 39.4 | -128.88 | -268.58 | |
| Earnings yield | 0 | 0 | 0 | 0.01 | 0 | |
| Free cash flow yield | 0.01 | 0.01 | 0.03 | -0.01 | 0 | |
| Debt to equity | 0.02 | 0.02 | 0.02 | 0 | 0 | |
| Debt to assets | 0.2 | 0.21 | 0.22 | 0.2 | 0.19 | |
| Net debt to EBITDA | -1.29 | -1.3 | -2.87 | 0 | 0 | |
| Current ratio | 2.17 | 2.05 | 1.74 | 1.95 | 1.95 | |
| Interest coverage | 0 | 0 | 0 | -51.46 | 3 | |
| Income quality | 3.19 | 2.57 | -7.49 | -0.46 | 0.3 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.04 | 0.55 | 0.68 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0 | 0 | |
| Capex to operating cash flow | -0.15 | -0.31 | -0.09 | 0.59 | 2.57 | |
| Capex to revenue | -0.02 | -0.03 | -0.02 | -0.03 | -0.03 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 36.8K | 30.29K | 30.97K | 51.79K | 26.43K | |
| ROIC | 0.02 | 0.01 | 0.01 | 0.03 | 0 | |
| Return on tangible assets | 0.01 | 0.01 | -0.01 | 0.02 | -0.01 | |
| Graham Net | 2.46K | 1.04K | 66.16 | -17.81K | -16.44K | |
| Working capital | 1106.05B | 1098.85B | 861.04B | 962.97B | 903.15B | |
| Tangible asset value | 4415.65B | 4642.05B | 4542.62B | 0 | 0 | |
| Net current asset value | 863.7B | 868.32B | 646.11B | 753.78B | 719.08B | |
| Invested capital | 0.08 | 0.08 | 0.08 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 40.05 | 43 | 29.22 | 0 | 0 | |
| Days of inventory on hand | 130.08 | 149.95 | 116.78 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.25 | 2.09 | 3.08 | 0 | 0 | |
| Inventory turnover | 0.69 | 0.6 | 0.77 | 0 | 0 | |
| ROE | 0.01 | 0.01 | -0.01 | 0.02 | -0.01 | |
| Capex per share | -421.2 | -457.66 | -435.4 | -462.86 | -348.6 |
Frequently Asked Questions
What is Amorepacific Corporation stock symbol ?
Amorepacific Corporation is a US stock and trading under the symbol 090430.KS
What is Amorepacific Corporation stock quote today ?
Amorepacific Corporation stock price is $102000 today.
Is Amorepacific Corporation stock public?
Yes, Amorepacific Corporation is a publicly traded company.
Company Profile
- Volume Average 207.21K
- Market Capitalization 6404.23B
- Employee 4.78K
- Headquarters Seoul,US
- IPO Date 2006-06-29
-
Website
https://www.amorepacific.com 
Amorepacific Corporation manufactures and sells beauty, household, and healthcare products worldwide. The company offers skincare products, cleansers, toners and fluids, moisturizers, eye care products, serums, masks, and special care and travel products. It provides anti-ageing, dryness, tone and texture, sun protection, and makeup products. The company was founded in 1945 and is based in Seoul, South Korea.
